🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

15 recruiting trials

for Wild-type ATTR Amyloidosis

A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting NCT07235462n/a17 sites📍 Multiple Locations📍 Multiple Locations📍 Multiple Locations Bayer · Tests: Acoramidis (356 mg film-coated tablets) ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis) NCT04561518n/a40 sites📍 La Jolla📍 Los Angeles📍 Jacksonville Alnylam Pharmaceuticals Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis NCT06465810n/a89 sites📍 La Jolla📍 Los Angeles📍 San Francisco AstraZeneca · Tests: Treatment of transthyretin (ATTR) amyloidosis in observational study setting ATTR Cardiac Amyloidosis in a Selected Population NCT06458374n/a1 site📍 Ålesund Helse Møre og Romsdal HF Study of Acoramidis in Patients With Transthyretin Amyloid Cardiomyopathy NCT07791160n/a1 site📍 Many Locations Bayer · Tests: Acoramidis NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on Tafamidis NCT06251778n/a1 site📍 Pavia Paolo Milani MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM) NCT06128629Phase 3132 sites📍 Tucson📍 Los Angeles📍 Los Angeles Intellia Therapeutics · Tests: NTLA-2001, Placebo A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, and Prognostic Impact. NCT06836011n/a8 sites📍 Graz📍 Vienna📍 Munich Medical University of Vienna ATTR Amyloid Cardiomyopathy: Characterization of Extracellular Vesicles as Potential Disease Stratifiers and Prognostic Biomarkers NCT07314268n/a1 site📍 São Paulo University of Sao Paulo General Hospital A Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyretin Amyloidosis With Cardiomyopathy Switch From Tafamidis to Acoramidis NCT07298044Phase 426 sites📍 Sankt Pölten📍 Vienna📍 Vienna Bayer · Tests: Acoramidis TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy NCT07052903Phase 3266 sites📍 La Jolla📍 Laguna Hills📍 Stanford Alnylam Pharmaceuticals · Tests: Nucresiran, Sterile Normal Saline (0.9% NaCl) Phenotyping and Characterization of wtATTR-CM (TRACE 1) NCT06291805n/a1 site📍 Aarhus Steen Hvitfeldt Poulsen Haemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt) NCT06318260Phase 1, Phase 21 site📍 Aarhus Steen Hvitfeldt Poulsen · Tests: Dobutrex Liver and Coagulation Disorders in Cardiac Transthyretin Amyloidosis NCT07766135n/a1 site📍 Messina University of Messina Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis NCT06034405n/a6 sites📍 Beverly Hills📍 Boston📍 Boston Columbia University · Tests: Tc99-PYP or Tc99-HDMP Scan
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy